Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [31] Impact of Pregnancy on the Course of Relapsing-Remitting Multiple Sclerosis
    Manganas, Alexandra
    Karp, Igor
    Roger, Elaine
    Duquette, Pierre
    NEUROLOGY, 2011, 76 (09) : A610 - A610
  • [32] Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study
    Ruocco, Heloisa H.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Oliveira, Celina
    Oliveira, Elaine C.
    Cendes, Fernando
    Damasceno, Benito P.
    Santos, Leonilda M. B.
    NEUROIMMUNOMODULATION, 2012, 19 (05) : 277 - 282
  • [33] Clinical features of 314 patients with relapsing-remitting multiple sclerosis
    Nogales-Gaete, Jorge
    Aracena, Rodrigo
    Cepeda-Zumaeta, Sergio
    Eloiza, Claudio
    Agurto, Paula
    Diaz, Vannia
    Labbe, Silvia
    Martinez, Sefora
    Flores, Jazmin
    Araya, Casandra
    REVISTA MEDICA DE CHILE, 2014, 142 (05) : 559 - 566
  • [34] Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing-Remitting Multiple Sclerosis: A Retrospective Cohort Study
    Fang, Xingwei
    Lu, Yaxin
    Fu, Yongmei
    Liu, Zifeng
    Kermode, Allan G.
    Qiu, Wei
    Ling, Li
    Liu, Chunxin
    BRAIN SCIENCES, 2023, 13 (06)
  • [35] Cytokine Profiling in Cerebrospinal Fluid of Patients with Newly Diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS): Associations between Inflammatory Biomarkers and Disease Activity
    Gebka-Kepinska, Barbara
    Adamczyk, Bozena
    Gebka, Dorota
    Czuba, Zenon
    Szczygiel, Jaroslaw
    Adamczyk-Sowa, Monika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [36] Neurosteroidogenesis: relevance of neurosteroid levels in cerebrospinal fluid of relapsing-remitting multiple sclerosis patients with acute relapse or stable disease
    Cerillo, I.
    Orefice, N. S.
    Orefice, G.
    Lanzillo, R.
    Morra, V. Brescia
    Vacca, G.
    Carotenuto, A.
    Sacca, F.
    Montella, S.
    Barbato, F.
    Spina, E.
    Avagliano, C.
    Cristiano, C.
    Cordiglieri, C.
    Calignano, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 342 - 342
  • [37] Neurosteroidogenesis: relevance of neurosteroid levels in cerebrospinal fluid of Relapsing-Remitting Multiple Sclerosis patients with acute relapse or stable disease
    Cerillo, I.
    Orefice, N. S.
    Orefice, G.
    Lanzillo, R.
    Morra, V. Brescia
    Vacca, G.
    Carotenuto, A.
    Sacca, F.
    Montella, S.
    Barbato, F.
    Spina, E.
    Avagliano, C.
    Cristiano, C.
    Cordiglieri, C.
    Calignano, A.
    JOURNAL OF NEUROLOGY, 2014, 261 : S231 - S231
  • [38] Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis
    Hodgkinson, S.
    Lizak, N.
    Butler, E.
    Lechner-Scott, J.
    Slee, M.
    McCombe, P.
    Shaw, C.
    Skibina, O.
    Vucic, S.
    Shuey, N.
    Barnett, M.
    Parratt, J.
    Butzkueven, H.
    Jack, D.
    Fabris, J.
    Kalincik, T.
    Jokubaitis, V. G.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP64 - NP65
  • [39] Relationship between atherosclerosis markers in patients with relapsing-remitting multiple sclerosis
    Karakatic, Sanja
    Fabjan, Tanja Hojs
    Magdic, Jozef
    Gorenjak, Mario
    Omerzu, Tomaz
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 856 - 856
  • [40] Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
    Herman, Stephanie
    Akerfeldt, Torbjorn
    Spjuth, Ola
    Burman, Joachim
    Kultima, Kim
    CELLS, 2019, 8 (02)